Barclays’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6
| Closed | -$11K | – | 3955 |
|
|
2021
Q3 | $11K | Buy |
6
+2
| +50% | +$3.67K | ﹤0.01% | 3742 |
|
|
2021
Q2 | $10K | Sell |
4
-24
| -86% | -$60K | ﹤0.01% | 3880 |
|
|
2021
Q1 | $118K | Buy |
28
+17
| +155% | +$71.6K | ﹤0.01% | 3319 |
|
|
2020
Q4 | $63K | Buy |
+11
| New | +$63K | ﹤0.01% | 3108 |
|
|
2018
Q2 | – | Sell |
-12
| Closed | -$64K | – | 4469 |
|
|
2018
Q1 | $64K | Sell |
12
-31
| -72% | -$165K | ﹤0.01% | 3379 |
|
|
2017
Q4 | $233K | Buy |
43
+33
| +330% | +$179K | ﹤0.01% | 2568 |
|
|
2017
Q3 | $93K | Sell |
10
-4
| -29% | -$37.2K | ﹤0.01% | 2725 |
|
|
2017
Q2 | $107K | Buy |
14
+5
| +56% | +$38.2K | ﹤0.01% | 2736 |
|
|
2017
Q1 | $57K | Buy |
+9
| New | +$57K | ﹤0.01% | 3057 |
|
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 3552 |
|
|
2016
Q3 | – | Sell |
-2
| Closed | -$26K | – | 3827 |
|
|
2016
Q2 | $26K | Buy |
+2
| New | +$26K | ﹤0.01% | 2760 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3883 |
|
|
2015
Q3 | – | Hold |
0
| – | -$2K | – | 4175 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3943 |
|